Previous Article | Next Article 
Journal of Virology, July 2001, p. 6135-6142, Vol. 75, No. 13
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.13.6135-6142.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Epstein-Barr Virus Immediate-Early Protein BRLF1
Induces the Lytic Form of Viral Replication through a Mechanism
Involving Phosphatidylinositol-3 Kinase Activation
Catherine Dayle
Darr,1
Amy
Mauser,1 and
Shannon
Kenney1,2,3,*
Lineberger Comprehensive Cancer
Center,1 Department of
Medicine,2 and Department of
Microbiology,3 University of North Carolina at
Chapel Hill, Chapel Hill, North Carolina 27599-7295
Received 8 December 2000/Accepted 3 April 2001
Expression of the Epstein-Barr virus (EBV) immediate-early (IE)
protein BRLF1 induces the lytic form of viral replication in most
EBV-positive cell lines. BRLF1 is a transcriptional activator that
binds directly to a GC-rich motif present in some EBV lytic gene
promoters. However, BRLF1 activates transcription of the other IE
protein, BZLF1, through an indirect mechanism which we previously
showed to require activation of the stress mitogen-activated protein
kinases. Here we demonstrate that BRLF1 activates
phosphatidylinositol-3 (PI3) kinase signaling in host cells. We show
that the specific PI3 kinase inhibitor, LY294002, completely abrogates
the ability of a BRLF1 adenovirus vector to induce the lytic form of
EBV infection, while not affecting lytic infection induced by a BZLF1
adenovirus vector. Furthermore, we demonstrate that the requirement for
PI3 kinase activation in BRLF1-induced transcriptional activation is
promoter dependent. BRLF1 activation of the SM early promoter (which
occurs through a direct binding mechanism) does not require PI3 kinase
activation, whereas activation of the IE BZLF1 and early BMRF1
promoters requires PI3 kinase activation. Thus, there are clearly two
separate mechanisms by which BRLF1 induces transcriptional activation.
*
Corresponding author. Mailing address: Lineberger
Comprehensive Cancer Center, University of North Carolina at Chapel
Hill, Chapel Hill, NC 27599-7295. Phone: (919) 966-1248. Fax: (919) 966-8212. E-mail: shann{at}med.unc.edu.
Journal of Virology, July 2001, p. 6135-6142, Vol. 75, No. 13
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.13.6135-6142.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Calderwood, M. A., Holthaus, A. M., Johannsen, E.
(2008). The Epstein-Barr Virus LF2 Protein Inhibits Viral Replication. J. Virol.
82: 8509-8519
[Abstract]
[Full Text]
-
Feng, W.-h., Kraus, R. J., Dickerson, S. J., Lim, H. J., Jones, R. J., Yu, X., Mertz, J. E., Kenney, S. C.
(2007). ZEB1 and c-Jun Levels Contribute to the Establishment of Highly Lytic Epstein-Barr Virus Infection in Gastric AGS Cells. J. Virol.
81: 10113-10122
[Abstract]
[Full Text]
-
Ho, C.-H., Hsu, C.-F., Fong, P.-F., Tai, S.-K., Hsieh, S.-L., Chen, C.-J.
(2007). Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its Promoter. J. Virol.
81: 4837-4847
[Abstract]
[Full Text]
-
Chua, H.-H., Lee, H.-H., Chang, S.-S., Lu, C.-C., Yeh, T.-H., Hsu, T.-Y., Cheng, T.-H., Cheng, J.-T., Chen, M.-R., Tsai, C.-H.
(2007). Role of the TSG101 Gene in Epstein-Barr Virus Late Gene Transcription. J. Virol.
81: 2459-2471
[Abstract]
[Full Text]
-
Hsu, T.-Y., Chang, Y., Wang, P.-W., Liu, M.-Y., Chen, M.-R., Chen, J.-Y., Tsai, C.-H.
(2005). Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal. J. Gen. Virol.
86: 317-322
[Abstract]
[Full Text]
-
Chang, Y., Lee, H.-H., Chang, S.-S., Hsu, T.-Y., Wang, P.-W., Chang, Y.-S., Takada, K., Tsai, C.-H.
(2004). Induction of Epstein-Barr Virus Latent Membrane Protein 1 by a Lytic Transactivator Rta. J. Virol.
78: 13028-13036
[Abstract]
[Full Text]
-
Feng, W.-h., Cohen, J. I., Fischer, S., Li, L., Sneller, M., Goldbach-Mansky, R., Raab-Traub, N., Delecluse, H.-J., Kenney, S. C.
(2004). Reactivation of Latent Epstein-Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas. JNCI J Natl Cancer Inst
96: 1691-1702
[Abstract]
[Full Text]
-
Li, Y., Mahajan, N. P., Webster-Cyriaque, J., Bhende, P., Hong, G. K., Earp, H. S., Kenney, S.
(2004). The C-Mer Gene Is Induced by Epstein-Barr Virus Immediate-Early Protein BRLF1. J. Virol.
78: 11778-11785
[Abstract]
[Full Text]
-
Hong, G. K., Delecluse, H.-J., Gruffat, H., Morrison, T. E., Feng, W.-H., Sergeant, A., Kenney, S. C.
(2004). The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1. J. Virol.
78: 4983-4992
[Abstract]
[Full Text]
-
Cooray, S.
(2004). The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol.
85: 1065-1076
[Abstract]
[Full Text]
-
Li, Y., Webster-Cyriaque, J., Tomlinson, C. C., Yohe, M., Kenney, S.
(2004). Fatty Acid Synthase Expression Is Induced by the Epstein-Barr Virus Immediate-Early Protein BRLF1 and Is Required for Lytic Viral Gene Expression. J. Virol.
78: 4197-4206
[Abstract]
[Full Text]
-
Feng, W.-h., Hong, G., Delecluse, H.-J., Kenney, S. C.
(2004). Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas. J. Virol.
78: 1893-1902
[Abstract]
[Full Text]
-
Kudoh, A., Daikoku, T., Sugaya, Y., Isomura, H., Fujita, M., Kiyono, T., Nishiyama, Y., Tsurumi, T.
(2004). Inhibition of S-Phase Cyclin-Dependent Kinase Activity Blocks Expression of Epstein-Barr Virus Immediate-Early and Early Genes, Preventing Viral Lytic Replication. J. Virol.
78: 104-115
[Abstract]
[Full Text]
-
Song, M. J., Deng, H., Sun, R.
(2003). Comparative Study of Regulation of RTA-Responsive Genes in Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8. J. Virol.
77: 9451-9462
[Abstract]
[Full Text]
-
Prince, S., Keating, S., Fielding, C., Brennan, P., Floettmann, E., Rowe, M.
(2003). Latent Membrane Protein 1 Inhibits Epstein-Barr Virus Lytic Cycle Induction and Progress via Different Mechanisms. J. Virol.
77: 5000-5007
[Abstract]
[Full Text]
-
Kraus, R. J., Perrigoue, J. G., Mertz, J. E.
(2002). ZEB Negatively Regulates the Lytic-Switch BZLF1 Gene Promoter of Epstein-Barr Virus. J. Virol.
77: 199-207
[Abstract]
[Full Text]
-
Song, M. J., Li, X., Brown, H. J., Sun, R.
(2002). Characterization of Interactions between RTA and the Promoter of Polyadenylated Nuclear RNA in Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8. J. Virol.
76: 5000-5013
[Abstract]
[Full Text]
-
Chang, P.-J., Shedd, D., Gradoville, L., Cho, M.-S., Chen, L.-W., Chang, J., Miller, G.
(2002). Open Reading Frame 50 Protein of Kaposi's Sarcoma-Associated Herpesvirus Directly Activates the Viral PAN and K12 Genes by Binding to Related Response Elements. J. Virol.
76: 3168-3178
[Abstract]
[Full Text]
-
Feng, W.-h., Israel, B., Raab-Traub, N., Busson, P., Kenney, S. C.
(2002). Chemotherapy Induces Lytic EBV Replication and Confers Ganciclovir Susceptibility to EBV-positive Epithelial Cell Tumors. Cancer Res.
62: 1920-1926
[Abstract]
[Full Text]